| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.574 | 36.627 | 40.502 | 61.179 | 86.898 | 86.841 | 102.154 | 115.645 | 146.512 | 169.085 |
| Total Income - EUR | 41.648 | 36.627 | 40.502 | 61.183 | 92.459 | 86.985 | 102.392 | 115.648 | 158.555 | 169.089 |
| Total Expenses - EUR | 37.595 | 24.228 | 33.217 | 39.578 | 46.743 | 48.030 | 86.979 | 75.452 | 96.039 | 78.010 |
| Gross Profit/Loss - EUR | 4.053 | 12.399 | 7.286 | 21.605 | 45.717 | 38.955 | 15.413 | 40.195 | 62.516 | 91.079 |
| Net Profit/Loss - EUR | 2.866 | 12.032 | 6.874 | 21.131 | 44.561 | 38.086 | 14.512 | 39.131 | 61.105 | 86.108 |
| Employees | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 4 | 4 | 4 |
Check the financial reports for the company - Chifanmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.837 | 12.004 | 11.304 | 8.509 | 56.944 | 68.932 | 106.203 | 88.246 | 52.596 | 76.976 |
| Current Assets | 19.027 | 32.838 | 28.454 | 49.034 | 45.076 | 36.206 | 18.754 | 42.444 | 24.165 | 78.783 |
| Inventories | 7.648 | 5.498 | 7.468 | 6.276 | 9.142 | 15.957 | 0 | 0 | 0 | 0 |
| Receivables | 3.239 | 483 | 3.848 | 5.963 | 2.149 | 3.668 | 9.564 | 34.714 | 21.017 | 64.995 |
| Cash | 8.139 | 26.857 | 17.138 | 36.795 | 33.785 | 16.581 | 9.191 | 7.730 | 3.148 | 13.788 |
| Shareholders Funds | 30.708 | 42.427 | 33.260 | 25.902 | 55.506 | 54.294 | 40.258 | 48.249 | 70.194 | 95.147 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.156 | 2.415 | 6.497 | 31.641 | 46.515 | 50.845 | 84.700 | 82.441 | 6.749 | 60.671 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Chifanmed Srl